Around the world today, mothers are being monitored for life-threatening conditions when they are giving ... IP refers to creations of the mind, such as a brand, logo, invention, design or artistic ...

Ransomware attacks have become an common occurrence in day-to-day life in Australia, and are a constant threat ... IP refers to creations of the mind, such as a brand, logo, invention, design or ...

Merck, a leading science and technology company, and Siemens deepened their cooperation aimed at taking smart manufacturing ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to ...

(RTTNews) - Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy KEYTRUDA (pembrolizumab), in combination with ...

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report). The associated price target is $140.00. Charlie CY Yang has ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Merck ( MRK 0.53%) stock has been a longtime winner for investors, returning 72% in the past five years. A major factor in ...

The approval marks first indication for Keytruda in MPM in the US, MPM is a rare, aggressive cancer around the lining of the lungs and chest Wednesday, the FDA approved Merck & Co Inc’s MRK ...

In an email, the company pointed out that the majority of patients in LITESPARK-005 received Welireg as their third or fourth-line treatment (87.4%) after being treated with PD-1/L1 inhibitor and ...

Blockbuster cancer drug combined with chemotherapy improved survival rates in a Phase 3 trial Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster ...